Table 5.
Fold change | p-Valuea | Coagulation components and regulatorsb |
---|---|---|
−1.1 | NS | Factor II, Prothrombin: C |
−1.8 | 0.04 | Factor III, Thromboplastin (Tissue Factor): E |
1.8 | NS | Factor V, Labile factor (accelerator globulin, accelerin): C |
−1.9 | NS | Factor VII, Serum (or tissue) prothrombin: E |
−2.5 | NS | Factor VIII, Anti-hemophilic factor A: I |
−2.7 | 0.04 | Factor IX, Christmas factor: |
−1.5 | NS | Factor X, Stuart Power factor: C |
1.5 | NS | Factor XI, Plasma thromboplastin antecedent (PTA): I |
−4.6 | NS | Factor XII, Hageman factor (contact factor): I |
−1.8 | NS | Factor XIII, Fibrin-stabilizing factor: C |
−2.9 | NS | Protein C: I and C |
−2.3 | 0.04 | Protein S: I and C |
−2.1 | NS | Thrombomodulin: I and C |
−5.0 | 0.04 | Kallekrein B1: I |
−2.4 | 0.04 | Tissue factor pathway inhibitor: E |
−6.5 | 0.04 | Plasmin: F |
−1.5 | NS | Von Willebrand factor: I and E |
−1.5 | NS | Plasminogen activator, urokinase: F |
Gene expression data and IPA analysis was subjected to FDR (Benjamini–Holchberg) correction. No significant difference (NS), FDR value at 0.05.
Components involved in intrinsic (I), extrinsic (E), or common (C) coagulation pathways or in fibrinolysis (F).